Lincoln Pharmaceuticals (NSE:LINCOLN) Inventories, Raw Materials & Components: ₹0 Mil (As of Mar. 2026)


NSE:LINCOLN Lincoln Pharmaceuticals Ltd NSE:LINCOLN
84 GF Score
Price ₹614.60
GF Value ₹706.28
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lincoln Pharmaceuticals Inventories, Raw Materials & Components?

Lincoln Pharmaceuticals NSE:LINCOLN -0.90% 84 Inventories, Raw Materials & Components is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:LINCOLN with a GF Score™ of 84/100 and a GF Value™ of ₹706.28 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Lincoln Pharmaceuticals's inventories, raw materials & components for the quarter that ended in Mar. 2026 was ₹0 Mil.

Lincoln Pharmaceuticals's annual raw materials increased from Mar. 2024 (₹224 Mil) to Mar. 2025 (₹294 Mil) but then declined from Mar. 2025 (₹294 Mil) to Mar. 2026 (₹0 Mil).

Lincoln Pharmaceuticals Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Lincoln Pharmaceuticals's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lincoln Pharmaceuticals Inventories, Raw Materials & Components Chart

Lincoln Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 270.18 206.33 224.02 293.63 0.00

Lincoln Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 293.63 0.00 0.00 0.00 0.00
NSE:LINCOLN
84GF Score
Lincoln Pharmaceuticals Ltd NSE:LINCOLN
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lincoln Pharmaceuticals Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ₹0 Mil mean?
Lincoln Pharmaceuticals (NSE:LINCOLN) has a Inventories, Raw Materials & Components of ₹0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Lincoln Pharmaceuticals and its competitors.
Is Lincoln Pharmaceuticals' Inventories, Raw Materials & Components too high?
Lincoln Pharmaceuticals' current Inventories, Raw Materials & Components is ₹0 Mil. Overall, Lincoln Pharmaceuticals has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lincoln Pharmaceuticals' Inventories, Raw Materials & Components compare to ZTS and UTHR?
Lincoln Pharmaceuticals' Inventories, Raw Materials & Components of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Lincoln Pharmaceuticals and its competitors. Lincoln Pharmaceuticals's current Inventories, Raw Materials & Components is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lincoln Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Lincoln Pharmaceuticals (NSE:LINCOLN) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹706.28, compared to a current price of ₹614.60 — trading 13% below its estimated fair value. The current Inventories, Raw Materials & Components is ₹0 Mil. Lincoln Pharmaceuticals' overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Lincoln Pharmaceuticals (NSE:LINCOLN), the current Inventories, Raw Materials & Components is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lincoln Pharmaceuticals (NSE:LINCOLN) Overvalued in 2026?

Based on GuruFocus' analysis, Lincoln Pharmaceuticals stock appears to be undervalued. The current stock price of ₹614.60 is trading 13% below its estimated GF Value™ of ₹706.28. GuruFocus considers Lincoln Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for NSE:LINCOLN:

  • Inventories, Raw Materials & Components: ₹0 Mil
  • GF Value™: ₹706.28 vs. price of ₹614.60 (13% below fair value)
  • GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the NSE:LINCOLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lincoln Pharmaceuticals Business Description

Other Exchanges 531633:India
Address Science City Road, Lincoln House, Behind Satyam Complex, Sola, Ahmedabad, GJ, IND, 380060
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.
84GF Score

Get the complete analysis for NSE:LINCOLN

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹614.60
Price
₹706.28
GF Value